Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study.
Lung Cancer
; 32(2): 179-87, 2001 May.
Article
in En
| MEDLINE
| ID: mdl-11325489
Search on Google
Collection:
01-internacional
Health context:
2_ODS3
/
3_ND
/
4_TD
/
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Granulocyte Colony-Stimulating Factor
/
Paclitaxel
/
Carcinoma, Non-Small-Cell Lung
/
Taxoids
/
Lung Neoplasms
/
Neutropenia
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Lung Cancer
Year:
2001
Document type:
Article